Vimarsana
Biggest News Aggregation in the World

Universal Registration Document News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Universal Registration Document. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Universal Registration Document Today - Breaking & Trending Today

Ipsen Pharma: Ipsen's Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis - Vimarsana News

Ipsen Pharma: Ipsen's Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Published: June 10, 2024

Iqirvo® (elafibranor) 80 mg tablets is the first new medicine approved in nearly a decade for the treatment of the rare liver

Source: finanznachrichten.de
Related Topics:
France GeneralUnited StatesUnited KingdomHong KongChristelle HuguetRachel ReiffKris KowdleyNicolas BoglerAnna GibbinsAmy WolfCarol RobertsClin Gastroenterol HepatolIpsen EuronextIpsen Pharmaceuticals IncRegulatory AgencyLiver InstituteHead Of ResearchDrug AdministrationFibrotic Liver Disease Consortium InvestigatorsIpsen PharmaceuticalsNewborn DevelopmentEuropean Medicines AgencyExecutive Vice PresidentNew England JournalImportant Safety Information
Soitec : FY24 Annual Results - MarketScreener - Vimarsana News

Soitec : FY24 Annual Results - MarketScreener

Published: May 30, 2024

FY24 RESULTS Paris | May 23rd, 2024 DISCLAIMER ...

Source: marketscreener.com
Related Topics:
United StatesNeither The CompanySoitec The CompanyCompany Universal Registration DocumentUniversal Registration DocumentAnnual Financial ReportRegistration DocumentDes MarchUniversal Registration
Clariane : publishes its Universal Registration Document 2023 including the Annual Financial Report and the Integrated Report - Vimarsana News

Clariane : publishes its Universal Registration Document 2023 including the Annual Financial Report and the Integrated Report

Published: May 29, 2024

Sommaire : 2023 - A year of resilience 2023 - An ESG strategy integral to the corporate p... ...

Source: marketscreener.com
Related Topics:
Sophie BoissardMission CommitteeClariane GroupRegistration DocumentUniversal Registration DocumentPositive CareTop Employer Europe
Innate Pharma SA: Innate Pharma Announces Its Participation in Upcoming Investor Conferences - Vimarsana News

Innate Pharma SA: Innate Pharma Announces Its Participation in Upcoming Investor Conferences

Published: May 28, 2024

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced members of its executive team are scheduled to participate in the upcoming conferences

Source: finanznachrichten.de
Related Topics:
United StatesNew YorkArthur RouillSonia QuaratinoHenry WheelerFrench Financial Markets AuthorityExchange CommissionGoldman SachsCompany Annual Report On FormRegulatory NewsEuronext ParisChief Executive OfficerExecutive Vice PresidentChief Medical OfficerYannis MorelChief Operating OfficerArvind SoodGlobal Healthcare ConferenceAnnual Global Healthcare ConferenceAnnual Immune Cell Engager Virtual ConferenceEuropean Healthcare Summit LyonEngager TherapeuticsInnate PharmaPrivate Securities Litigation Reform ActRisk Factors
Aramis Group - 2024 first-half results - MarketScreener - Vimarsana News

Aramis Group - 2024 first-half results - MarketScreener

Published: May 27, 2024

PRESS RELEASE Arcueil, May 27, 2024 2024 first-half results Acceleration of profitable growth: +26% in volumes and sharp...

Source: marketscreener.com
Related Topics:
France GeneralUnited StatesUnited KingdomNicolas ChartierGuillaume PaoliAlexandre LeroyStellantis GroupDaramis GroupAramis Group Board Of DirectorsGroup ItalianFrench Financial Markets AuthorityCapital Markets DayMarkets DayUniversal Registration DocumentInvestor RelationsPromoter ScoreChief Executive OfficerDeputy Chief Executive Officer